메뉴 건너뛰기




Volumn 127, Issue 2, 2009, Pages 146-152

Value-based medicine, comparative effectiveness, and cost-effectiveness analysis of topical cyclosporine for the treatment of dry eye syndrome

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; LUBRICATING AGENT; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

EID: 60549083152     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2008.608     Document Type: Article
Times cited : (53)

References (57)
  • 2
    • 0037645975 scopus 로고    scopus 로고
    • Prevalence of dry eye among an elderly Chinese population in Taiwan: The Shihpai Eye Study
    • Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P, Hsu WM. Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology. 2003;110(6):1096-1101.
    • (2003) Ophthalmology , vol.110 , Issue.6 , pp. 1096-1101
    • Lin, P.Y.1    Tsai, S.Y.2    Cheng, C.Y.3    Liu, J.H.4    Chou, P.5    Hsu, W.M.6
  • 3
    • 0035164394 scopus 로고    scopus 로고
    • Dry eye disease: The scale of the problem
    • Brewitt H, Sistani F. Dry eye disease: the scale of the problem. Surv Ophthalmol. 2001;45(suppl 2):S199-S202.
    • (2001) Surv Ophthalmol , vol.45 , Issue.SUPPL. 2
    • Brewitt, H.1    Sistani, F.2
  • 5
    • 0027510403 scopus 로고
    • The Beaver Dam Health Outcomes Study: Initial catalog of health-state quality factors
    • Fryback DG, Dasbach EJ, Klein R, et al.The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making. 1993;13(2):89-102.
    • (1993) Med Decis Making , vol.13 , Issue.2 , pp. 89-102
    • Fryback, D.G.1    Dasbach, E.J.2    Klein, R.3
  • 7
    • 0018155086 scopus 로고
    • The utility of different health states as perceived by the general public
    • Sackett DL, Torrance GW. The utility of different health states as perceived by the general public. J Chronic Dis. 1978;31(11):697-704.
    • (1978) J Chronic Dis , vol.31 , Issue.11 , pp. 697-704
    • Sackett, D.L.1    Torrance, G.W.2
  • 8
    • 0036850062 scopus 로고    scopus 로고
    • A meta-analysis of utility estimates for HIV/AIDS
    • Tengs TO, Lin TH. A meta-analysis of utility estimates for HIV/AIDS. Med Decis Making. 2002;22(6):475-481.
    • (2002) Med Decis Making , vol.22 , Issue.6 , pp. 475-481
    • Tengs, T.O.1    Lin, T.H.2
  • 10
    • 34147142303 scopus 로고    scopus 로고
    • Clinical performance of a mid-viscosity artificial tear for dry eye treatment
    • Simmons PA, Vehige JG. Clinical performance of a mid-viscosity artificial tear for dry eye treatment. Cornea. 2007;26(3):294-302.
    • (2007) Cornea , vol.26 , Issue.3 , pp. 294-302
    • Simmons, P.A.1    Vehige, J.G.2
  • 11
    • 22444448251 scopus 로고    scopus 로고
    • Silicone versus collagen plugs for treating dry eye: Results of a prospective randomized trial including lacrimal scintigraphy
    • Altan-Yaycioglu R, Gencoglu EA, Akova YA, Dursun D, Cengiz F, Akman A. Silicone versus collagen plugs for treating dry eye: results of a prospective randomized trial including lacrimal scintigraphy. Am J Ophthalmol. 2005;140(1):88-93.
    • (2005) Am J Ophthalmol , vol.140 , Issue.1 , pp. 88-93
    • Altan-Yaycioglu, R.1    Gencoglu, E.A.2    Akova, Y.A.3    Dursun, D.4    Cengiz, F.5    Akman, A.6
  • 13
    • 0018233657 scopus 로고
    • Punctal occlusion in keratoconjunctivitis sicca
    • Dohlman CH. Punctal occlusion in keratoconjunctivitis sicca. Ophthalmology. 1978:85(12):1277-1281.
    • (1978) Ophthalmology , vol.85 , Issue.12 , pp. 1277-1281
    • Dohlman, C.H.1
  • 14
    • 0022980246 scopus 로고
    • The autoimmune nature of aqueous tear deficiency
    • Pflugfelder SC, Jones D, Ji Z, et al. The autoimmune nature of aqueous tear deficiency. Ophthalmology. 1986;93(12):1513-1517.
    • (1986) Ophthalmology , vol.93 , Issue.12 , pp. 1513-1517
    • Pflugfelder, S.C.1    Jones, D.2    Ji, Z.3
  • 15
    • 33947364762 scopus 로고    scopus 로고
    • Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren's syndrome
    • Hong S, Kim T, Chung SH, Kim EK, Seo KY. Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren's syndrome. J Ocul Pharmacol Ther. 2007;23(1):78-82.
    • (2007) J Ocul Pharmacol Ther , vol.23 , Issue.1 , pp. 78-82
    • Hong, S.1    Kim, T.2    Chung, S.H.3    Kim, E.K.4    Seo, K.Y.5
  • 16
    • 34250192888 scopus 로고    scopus 로고
    • Systemic immunomodulatory therapy in severe dry eye secondary to inflammation
    • Cordero-Coma M, Anzaar F, Sobrin L, Foster CS. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation. Ocul Immunol Inflamm. 2007;15(2):99-104.
    • (2007) Ocul Immunol Inflamm , vol.15 , Issue.2 , pp. 99-104
    • Cordero-Coma, M.1    Anzaar, F.2    Sobrin, L.3    Foster, C.S.4
  • 17
    • 0027954030 scopus 로고
    • Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjögren's syndrome
    • Günd̈z K, Ozdemir O. Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjögren's syndrome. Acta Ophthalmol (Copenh). 1994;72(4):438-442.
    • (1994) Acta Ophthalmol (Copenh) , vol.72 , Issue.4 , pp. 438-442
    • Günd̈z, K.1    Ozdemir, O.2
  • 18
    • 0034105080 scopus 로고    scopus 로고
    • CsA Phase 3 Study Group. Two randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease
    • Sall K, Stevenson OD, Mundorf TK, Reis BL; CsA Phase 3 Study Group. Two randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology. 2000;107(4):631-639.
    • (2000) Ophthalmology , vol.107 , Issue.4 , pp. 631-639
    • Sall, K.1    Stevenson, O.D.2    Mundorf, T.K.3    Reis, B.L.4
  • 19
    • 0033801265 scopus 로고    scopus 로고
    • Efficacy and safety of cyclosporine A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: A dose-ranging, randomized trial: the Cyclosporin A Phase 2 Study Group
    • Stevenson D, Tauber J, Reis BL. Efficacy and safety of cyclosporine A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial: the Cyclosporin A Phase 2 Study Group. Ophthalmology.2000;107(5):967-974.
    • (2000) Ophthalmology , vol.107 , Issue.5 , pp. 967-974
    • Stevenson, D.1    Tauber, J.2    Reis, B.L.3
  • 20
    • 0033822741 scopus 로고    scopus 로고
    • The diagnosis and management of dry eye: A twenty-five-year review
    • Pflugfelder SC, Solomon A, Stern ME. The diagnosis and management of dry eye: a twenty-five-year review. Cornea. 2000;19(5):644-649.
    • (2000) Cornea , vol.19 , Issue.5 , pp. 644-649
    • Pflugfelder, S.C.1    Solomon, A.2    Stern, M.E.3
  • 21
    • 25844450960 scopus 로고    scopus 로고
    • Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years
    • Barber LD, Pflugfelder SC, Tauber J, Foulks GN. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years. Ophthalmology. 2005;112(10):1790-1794.
    • (2005) Ophthalmology , vol.112 , Issue.10 , pp. 1790-1794
    • Barber, L.D.1    Pflugfelder, S.C.2    Tauber, J.3    Foulks, G.N.4
  • 22
    • 60849107840 scopus 로고    scopus 로고
    • Restatis (cyclosporine ophthalmic emulsion) 0.05%. Allergan Inc Web site. http://www.restasisprofessional.com. Accessed April 8, 2008.
    • Restatis (cyclosporine ophthalmic emulsion) 0.05%. Allergan Inc Web site. http://www.restasisprofessional.com. Accessed April 8, 2008.
  • 24
    • 0037353837 scopus 로고    scopus 로고
    • Health care economic analyses and value-based medicine
    • Brown MM, Brown GC, Sharma S, Landy J. Health care economic analyses and value-based medicine. Surv Ophthalmol. 2003;48(2):204-223.
    • (2003) Surv Ophthalmol , vol.48 , Issue.2 , pp. 204-223
    • Brown, M.M.1    Brown, G.C.2    Sharma, S.3    Landy, J.4
  • 25
    • 33750796886 scopus 로고    scopus 로고
    • Value-based medicine: A paradigm for quality pharmaceutical care
    • Brown MM, Brown GC, Sharma S. Value-based medicine: a paradigm for quality pharmaceutical care. Drug Benefit Trends. 2006;18:285-289.
    • (2006) Drug Benefit Trends , vol.18 , pp. 285-289
    • Brown, M.M.1    Brown, G.C.2    Sharma, S.3
  • 26
    • 0036241252 scopus 로고    scopus 로고
    • Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients
    • Sharma S, Brown GC, Brown MM, Hollands H, Robins R, Shah GK. Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients. Br J Ophthalmol. 2002;86(5):493-496.
    • (2002) Br J Ophthalmol , vol.86 , Issue.5 , pp. 493-496
    • Sharma, S.1    Brown, G.C.2    Brown, M.M.3    Hollands, H.4    Robins, R.5    Shah, G.K.6
  • 27
    • 0036690670 scopus 로고    scopus 로고
    • Patient, community and clinician perceptions of the quality of life associated with diabetes mellitus
    • Landy J, Stein JD, Brown GC, Brown MM, Sharma S. Patient, community and clinician perceptions of the quality of life associated with diabetes mellitus. Med Sci Monit. 2002;8(8):CR543-CR548.
    • (2002) Med Sci Monit , vol.8 , Issue.8
    • Landy, J.1    Stein, J.D.2    Brown, G.C.3    Brown, M.M.4    Sharma, S.5
  • 28
    • 0033675436 scopus 로고    scopus 로고
    • Difference between ophthalmologist and patient perceptions of quality-of-life associated with age-related macular degeneration
    • Brown GC, Brown MM, Sharma S. Difference between ophthalmologist and patient perceptions of quality-of-life associated with age-related macular degeneration. Can J Ophthalmol. 2000;35(3):127-133.
    • (2000) Can J Ophthalmol , vol.35 , Issue.3 , pp. 127-133
    • Brown, G.C.1    Brown, M.M.2    Sharma, S.3
  • 31
    • 0036145093 scopus 로고    scopus 로고
    • Quality-of-life and systemic comorbidities in patients with ophthalmic disease
    • Brown MM, Brown GC, Sharma S, Hollands H, Landy J. Quality-of-life and systemic comorbidities in patients with ophthalmic disease. Br J Ophthalmol. 2002:86(1):8-11.
    • (2002) Br J Ophthalmol , vol.86 , Issue.1 , pp. 8-11
    • Brown, M.M.1    Brown, G.C.2    Sharma, S.3    Hollands, H.4    Landy, J.5
  • 33
    • 0012164128 scopus 로고    scopus 로고
    • Center for Drug Evaluation and Research application 21-023, Accessed April 4, 2008
    • Center for Drug Evaluation and Research application 21-023. Center for Drug Evaluation and Research Web site. http://www.fda.gov/cder/foi/nda/2003/21- 023-Restasis-Medr.PDF. Accessed April 4, 2008.
    • Center for Drug Evaluation and Research Web site
  • 34
    • 0035081975 scopus 로고    scopus 로고
    • Utility values associated with blindness in an adult population
    • Brown MM, Brown GC, Sharma S, Kistler J, Brown H. Utility values associated with blindness in an adult population. Br J Ophthalmol. 2001;85(3):327-331.
    • (2001) Br J Ophthalmol , vol.85 , Issue.3 , pp. 327-331
    • Brown, M.M.1    Brown, G.C.2    Sharma, S.3    Kistler, J.4    Brown, H.5
  • 35
    • 0033370961 scopus 로고    scopus 로고
    • Vision and quality of life
    • Brown GC. Vision and quality of life. Trans Am Ophthalmol Soc. 1999;97:473-512.
    • (1999) Trans Am Ophthalmol Soc , vol.97 , pp. 473-512
    • Brown, G.C.1
  • 36
    • 0033986170 scopus 로고    scopus 로고
    • Utility values and age-related macular degeneration
    • Brown GC, Sharma S, Brown MM, Kistler J. Utility values and age-related macular degeneration. Arch Ophthalmol. 2000;118(1):47-51.
    • (2000) Arch Ophthalmol , vol.118 , Issue.1 , pp. 47-51
    • Brown, G.C.1    Sharma, S.2    Brown, M.M.3    Kistler, J.4
  • 37
    • 0036305925 scopus 로고    scopus 로고
    • Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration
    • Brown MM, Brown GC, Sharma S, Landy J, Bakal J. Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration. Arch Ophthalmol. 2002;120(4):481-484.
    • (2002) Arch Ophthalmol , vol.120 , Issue.4 , pp. 481-484
    • Brown, M.M.1    Brown, G.C.2    Sharma, S.3    Landy, J.4    Bakal, J.5
  • 39
    • 44349110000 scopus 로고    scopus 로고
    • Brown GC, Brown MM, Brown H, Peet JS. A value-based medicine analysis of ranibizumab (MARINA Study) for the treatment of subfoveal neovascular macular degeneration [published online ahead of print November 5, 2007]. Ophthalmology. 2008;115(6):1039-1045.e5.
    • Brown GC, Brown MM, Brown H, Peet JS. A value-based medicine analysis of ranibizumab (MARINA Study) for the treatment of subfoveal neovascular macular degeneration [published online ahead of print November 5, 2007]. Ophthalmology. 2008;115(6):1039-1045.e5.
  • 41
    • 36148967079 scopus 로고    scopus 로고
    • Centers for Medicare and Medicaid Services physician fee schedule overview, Accessed September 20, 2007
    • Centers for Medicare and Medicaid Services physician fee schedule overview. Centers for Medicare and Medicaid Services Web site. http://www.cms.hhs.gov/apps/ama/license.asp?file=physicianfeesched/downloads/ pe-townhall-hcpcs-level.zip. Accessed September 20, 2007.
    • Centers for Medicare and Medicaid Services Web site
  • 42
    • 60849131336 scopus 로고    scopus 로고
    • Current procedural terminology, fourth edition. American Medical Association Web site. https://catalog.ama-assn.org/Catalog/cpt/cpt-search.jsp? check-Xwho=done. Accessed February 15, 2008.
    • Current procedural terminology, fourth edition. American Medical Association Web site. https://catalog.ama-assn.org/Catalog/cpt/cpt-search.jsp? check-Xwho=done. Accessed February 15, 2008.
  • 46
    • 0029919387 scopus 로고    scopus 로고
    • Panel on Cost-Effectiveness in Health and Medicine. Recommendations for reporting cost-effectiveness analyses
    • Siegel JE, Weinstein MC, Russell LB, Gold MR; Panel on Cost-Effectiveness in Health and Medicine. Recommendations for reporting cost-effectiveness analyses. JAMA. 1996;276(16):1339-1341.
    • (1996) JAMA , vol.276 , Issue.16 , pp. 1339-1341
    • Siegel, J.E.1    Weinstein, M.C.2    Russell, L.B.3    Gold, M.R.4
  • 47
    • 60849104582 scopus 로고    scopus 로고
    • The Guidelines Manual chapter 8: incorporating health economics in guidelines and assessing resource impact. National Institute for Health and Clinical Excellence Web site. http://www.nice.org.uk/niceMedia/pdf/ GuidelinesManualChapter8.pdf. Accessed April 3, 2008.
    • The Guidelines Manual chapter 8: incorporating health economics in guidelines and assessing resource impact. National Institute for Health and Clinical Excellence Web site. http://www.nice.org.uk/niceMedia/pdf/ GuidelinesManualChapter8.pdf. Accessed April 3, 2008.
  • 48
    • 60849135218 scopus 로고    scopus 로고
    • The world health report 2002: reducing risks, promoting health life. World Health Organization Web site. www.who.int/whr/2002/en/. Accessed May 17, 2008.
    • The world health report 2002: reducing risks, promoting health life. World Health Organization Web site. www.who.int/whr/2002/en/. Accessed May 17, 2008.
  • 49
    • 34247326604 scopus 로고    scopus 로고
    • Value-based medicine and interventions for macular degeneration
    • Brown MM, Brown GC, Brown H. Value-based medicine and interventions for macular degeneration. Curr Opin Ophthalmol. 2007;18(3):194-200.
    • (2007) Curr Opin Ophthalmol , vol.18 , Issue.3 , pp. 194-200
    • Brown, M.M.1    Brown, G.C.2    Brown, H.3
  • 50
    • 34247248392 scopus 로고    scopus 로고
    • A value-based medicine comparison of interventions for subfoveal neovascular macular degeneration
    • Brown GC, Brown MM, Brown HC, Kindermann S, Sharma S. A value-based medicine comparison of interventions for subfoveal neovascular macular degeneration Ophthalmology. 2007;114(6):1170-1178.
    • (2007) Ophthalmology , vol.114 , Issue.6 , pp. 1170-1178
    • Brown, G.C.1    Brown, M.M.2    Brown, H.C.3    Kindermann, S.4    Sharma, S.5
  • 51
    • 0037583136 scopus 로고    scopus 로고
    • A cost-utility analysis of cataract surgery in the second eye
    • Busbee BG, Brown MM, Brown GC, Sharma S. A cost-utility analysis of cataract surgery in the second eye. Ophthalmology. 2003;110(12):2310- 2317.
    • (2003) Ophthalmology , vol.110 , Issue.12 , pp. 2310-2317
    • Busbee, B.G.1    Brown, M.M.2    Brown, G.C.3    Sharma, S.4
  • 52
    • 0036184981 scopus 로고    scopus 로고
    • Incremental cost-effectiveness of initial cataract surgery
    • Busbee BG, Brown MM, Brown GC, Sharma S. Incremental cost-effectiveness of initial cataract surgery. Ophthalmology. 2002;109(3):606-612.
    • (2002) Ophthalmology , vol.109 , Issue.3 , pp. 606-612
    • Busbee, B.G.1    Brown, M.M.2    Brown, G.C.3    Sharma, S.4
  • 54
    • 0030963729 scopus 로고    scopus 로고
    • Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV
    • Pinkerton SD, Holtgrave DR, Pinkerton HJ. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV. Arch Intern Med. 1997;157(17):1972-1980.
    • (1997) Arch Intern Med , vol.157 , Issue.17 , pp. 1972-1980
    • Pinkerton, S.D.1    Holtgrave, D.R.2    Pinkerton, H.J.3
  • 55
    • 0033890241 scopus 로고    scopus 로고
    • Antiviral therapies for herpes zoster infections: Are they economically justifiable?
    • Smith KJ, Roberts MS. Antiviral therapies for herpes zoster infections: are they economically justifiable? Pharmacoeconomics. 2000;18(2):95-104.
    • (2000) Pharmacoeconomics , vol.18 , Issue.2 , pp. 95-104
    • Smith, K.J.1    Roberts, M.S.2
  • 56
    • 0037292467 scopus 로고    scopus 로고
    • A cost-utility analysis of mitoxantrone hydrochloride and interferon beta-1b in the treatment of patients with secondary progressive or progressive relapsing multiple sclerosis
    • Touchette DR, Durgin TL, Wanke LA, Goodkin DE. A cost-utility analysis of mitoxantrone hydrochloride and interferon beta-1b in the treatment of patients with secondary progressive or progressive relapsing multiple sclerosis. Clin Ther. 2003;25(2):611-634.
    • (2003) Clin Ther , vol.25 , Issue.2 , pp. 611-634
    • Touchette, D.R.1    Durgin, T.L.2    Wanke, L.A.3    Goodkin, D.E.4
  • 57
    • 0036129303 scopus 로고    scopus 로고
    • Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine
    • Kunert KS, Tisdale AS, Gipson IK. Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine. Arch Ophthalmol. 2002;120(3):330-337.
    • (2002) Arch Ophthalmol , vol.120 , Issue.3 , pp. 330-337
    • Kunert, K.S.1    Tisdale, A.S.2    Gipson, I.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.